Literature DB >> 28101476

Psychometric Properties of the Persian Version of the Quality of Life in Epilepsy Inventory in the Later Life.

Abdolrahim Asadollahi1, Laleh Fani Saberi2, Ali Havasi3, Mohammad-Hossein Kaveh4.   

Abstract

BACKGROUND AND
PURPOSE: The reports indicate on the incidence of seizure disorder about 1.5 per cent of the normal elderly population. The Quality of Life in Epilepsy Inventory (QOLIE-31) has been pervasive simple tool to screen seizure in the busy neurophysiological settings and monitoring. It was constructed as self-administered tool in two formats, 89 and 31-items. To the reliability and validity of the QOLIE-31 across older adults in the southwest Iran and discuss its role in the detection of health-related quality of elderly patients with epilepsy.
METHODS: About 73 older adults (mean age = 66.3 ± 1.71) were sampled from the eight hospitals and caring centres. They replied to the QOLIE-31. External and criterion validity was calculated by correlation to the SF-36 questionnaire, to check and validate the epilepsy specific dimensions. The QOLIE-31 includes seven subscales: overall quality of life, seizure worry, emotional well-being, energy/fatigue, cognitive, medication effects, and social function.
RESULTS: There was significant difference within sample groups regarding main variables (p < 0.05). The coefficients of Cronbach's alpha (α= 0.76), convergent validity (0.81), divergent validity (-0.21), external validity with overall score of SF-36 (0.87), and criterion validity (0.78) were estimated, which were significant at p < 0.01. The exploratory factor analysis demonstrated that the QOLIE-31 is organized into six factors, which clarifies 92 per cent of the scale's variance. Second-order confirmatory factor analysis pointed out that the factor is well matched up onto a principal factor. Consequently, the 6-factors model was well appropriate for the data by the fit index techniques for adjusting the scale (AGFI = 0.94, GFI = 0.96, RMSEA = 0.003, IFI = 0.90, NFI = 0.95, CFI = 0.95).
CONCLUSIONS: The results pointed to the well-adjusted reliability and psychometric properties of the QOLIE-31 and its usefulness for the relevant studies as well.

Entities:  

Keywords:  Epilepsy; Iran; Older adults; QOLIE-31; SF-36; Seizure; Validity & reliability

Year:  2016        PMID: 28101476      PMCID: PMC5206101          DOI: 10.14581/jer.16012

Source DB:  PubMed          Journal:  J Epilepsy Res        ISSN: 2233-6249


Introduction

Epilepsy is a condition of decreasing neuronal system that usually begins to occur at any years of age. It is the most common neurological disorder-affecting people of all ages and is important to understand that epilepsy is a physical rather than mental disorder. There may be a problem by refusing to even talk about the symptoms. There are many different types of seizure, which are divided into two main groups i.e. generalized seizures, which occur when the disturbance is spread across all of the brain, and the second is partial seizures when only part of the brain is affected.1,2 Epilepsy can affect anyone at any time of life. It is more usually diagnosed in people under the age of 20 or those aged over 60. Most seizures are short-lived and need no medical attention.3–7 Over ten thousand articles on seizure (or epilepsy) for juveniles and youths can be found, but relatively less has been conducted on the older adults’ equivalent.8–10 The ratio of published studies of seizure within young adults to older adults is approximately 1:100.4,11–13 Attaining knowledge regarding epilepsy among elderly people will help the care-givers and gerontologists to achieve the ultimate goal of a dignified healthy ageing,14–17 and maintain the highest quality of life.8,18–21 Thus, it is adding life to years and not simply years to life.22,23 While ignorance about elderly seizure, having an instrument turns out to be a necessity.9,24–27 It is helpful even in the clinical treatment as well.28 The study was investigated to the standards of quality of life in epilepsy inventory in the later life, the shortened version (QOLIE-31) (1993, 2005) within older adults to introduce a relevant criterion. The measurement of external validity had contained correlating relation of the SF-36 and QOLIE-31 Inventories, to check the properties of the epilepsy specific dimensions.

Methods

About 73 men and women with age range of 57 to 91 and with the mean age of 66.3 ± 1.71 were sampled with the cluster-ratio sampling method from the eight medical centres and hospitals of Khuzistan province in the southwest Iran. The aged samples replied to the 31 items of QOLIE-31. The QOLIE-31 questionnaire mainly consists of a 31-item disability/symptom scale regarding epilepsy that was investigated by authors and literature reviews.2,4,7,12,13,20,22,24,27,29 It was developed in three version i.e. 89, 31, and 10 items. The 31 items is most common used version of QOLIE-31. Each item in the scale has several responses i.e. six response options from 1 = all of the time to 6 = none of the time severe (Item No: 2–12), four response options from 1 = very fearful to 4 = not fearful at all (Item No: 15–24). In addition, other formats have five response options from 1=not at all bothersome to 5=extremely bothersome (Item No: 25–30), and three closed-form and shaped items. If the 31 items are completed, a scale score ranging from 25 (no symptoms) to 125 (most severe symptoms), can be calculated. The QOLIE-31 contains 31 items on the following domains: overall quality of life (OQ), emotional wellbeing (EW), energy-fatigue (EF), cognitive functioning (CF), medication effects (ME), seizure worry (SW), and Social functioning (SF).

External and Criterion Validity

It was estimated by the correlations of overall scores of QOLIE-31 and its domains to other similar instrument like SF-36. The Pearson’s correlation coefficients was used to measure the relationship between scales of QOLIE-31 and SF-36. Strong correlations were expected between domains and scales with the same content. The SF-36 range from 0 to 100, with 100 representing the highest level of functioning possible in the QoL.

Translating the Instrument

Psychometric properties of the QOLIE-31 was evaluated in several divergent backgrounds and cultural groups i.e. Spanish, German, Thai, Norwegian, French, Italian, Portuguese, Serbian, Bulgarian, and Czech context.2,19,30–35 The study translated it into Persian from its English version4,12 by three instructors and an English language expert. The four translated versions were compared by the authors, and the researchers developed a common Persian text from them. Afterwards, the Persian version of the QOLIE-31 was translated back into English by an English language expert who had not seen the original English text and by a linguist. The English statements of the questionnaire that had been translated from Persian into English were compared with the original version, and any necessary revisions were made as well.

Setting and Participants

From the eight medical centres and hospitals of Khuzistan province in the southwest Iran, about 80 aged men who had been constant patients at the centers responded to the Iranian version of the QOLIE-31. Of the 80 responders, 73 had responded to all of the 31 items used in the inventory and included in the analysis. The mean age of the samples was 66.3 ± 1.71 (range 57–91) years.

Results

About 73 elderly patients were the samples of the study, 45 men (79.5%) and 28 women (20.4%) with a mean age of 68.9 years of old (standard deviation [SD] = 7.77). All of patients were replied to both inventories of study, QOLIE-31 and SF-36. The demographic characteristics are shown in Table 1 and clinical characteristics in Table 2. The comparing QOLIE-31 overall score made between elderly males and females regarding their health status, education, occupation, marital status, and other demographic characteristics, type of epilepsy, etiology, seizure type, seizure severity, and antiepileptic drugs, revealed statistically significant difference within samples.
Table 1

Frequency distribution and comparison of seniors’ demographic and background profiles by gender (n = 73, p ≤ 0.05)

CategoriesSub Itemsn%MaleFemaleχ2/ρ-value
GenderMale4579.56--1.105/ 0.000
Female2820.44--
Age (Mean = 66.3, SD = 1.71)60–70 (young old)3649.3220162.125/0.000
71–80 (middle old)2128.77138
≥ 81 (old old)1621.9288
EthnicityPersian3041.1015154.142/0.000
Arab2230.14184
Lor2128.77165
Educational statusNo formal school5271.23213112.5/ 0.000
Only reading1723.29107
Primary22.7420
Middle school11.3710
High school00.0000
Graduated11.3710
Marital statusDivorced11.371032.4/0.000
Widowed2128.77714
Separated00.0000
Married4358.903112
Never married22.7402
Living with other68.2206
Length of married time (Mean = 29.3, SD = 3.27) [national range: Mean = 25.1 and SD = 3.1]≤ 10 year912.339021.61/ 0.000
11–20 year1520.55105
21–30 year4764.383314
≥ 31 year22.7402
Family members (Mean = 5.7, SD = 1.34)≤ 5 persons4156.16202123.8/ 0.005
≥ 6 persons3243.841517
Economic support and pensioningNothing5271.23124021.3/0.000
Public1926.03109
Private22.7420
Range of financial support upon urban poverty ratio* (Mean = 936439.79, SD = 1.48)Nothing4865.75361223.5/0.000
≤ 990,0001013.7055
1000000–4500000810.9680
4510000–799000056.8550
≥ 800000022.7420
Municipal zones1= Middle Class1216.446634.01/0.059
2= Developed810.9653
3= Developed810.9635
4= Undeveloped1317.81103
5= Undeveloped79.5943
6= Middle Class45.4822
7= Middle Class912.3354
8= Undeveloped1216.4457

Based on Iranian Rials currency and 1 US$= 29060 IR Rials in 2014.

They are economically divided into three parts i.e. poor and undeveloped = 29.6% (zone 4, 5, & 8), middle class= 48.6% (zone 1, 6, & 7), wealthy and developed = 21.8% (zone 2 & 3) regarding income of citizens and urban facilities based on Provincial Report of KSCC (2011).

Table 2

Frequency distribution and comparison of seniors’ clinical characteristics profiles by gender (n = 73, p ≤ 0.05)

CategoriesSub Itemsn%MaleFemaleχ2/ρ-value
Type of epilepsyTonic-clonic3142.47171421.01/0.009
Partial2027.4416
Absence1317.81103
Others912.3363
EtiologyIdiopathic2230.1416632.00/0.001
Symptomatic3852.061523
Cryptogenic1317.81112
Seizure typeAbsence79.593413.8/0.001
Myoclonic1115.0756
Primarily generalized tonic-clonic1419.1868
Simple partial1824.66117
Complex partial912.3381
Secondarily generalized tonic-clonic1419.1895
Seizure severityControlled1824.6610822.08/0.000
Low1317.8194
Moderate1824.66513
High1013.7073
Very High1419.18104
Antiepileptic drugsTherapy withdrawn3852.06172112.00/0.010
Monotherapy2432.881113
Polytherapy1115.0783
Duration Total = Mean: 17.02 years, Range: 2–63 year14.04/0.000
 Male = Mean: 19.11 years, Range: 1–63 years
 Female = Mean: 16.13 years, Range: 3–56 years

Internal Consistency

The coefficients of Cronbach’s alpha (α = 0.89), convergent validity (0.81), divergent validity (−0.21), and criterion validity (0.78) were estimated, which were significant at ρ < 0.01. The discriminative power in the QOLIE-31 of sub-scales with overall score using Kolmogorov-Smirnov and Shapiro-Wilk tests of normality demonstrated an almost normal distribution (Table 3). Mean overall score was 52.5 (CI = 38–67) and SD = 19.42. Discriminative power testing showed that domains showed an almost normal distribution (Table 3).
Table 3

Descriptive statistics and discriminative power in the QOLIE-31 of sub-scales with overall score

Domains (Item Number)No. of itemsMean (95%CI)*MedianSDCronbach’s αKSSVdfρ-value
Seizure worry (11,21,22,23,25)554.5 (28–81)5326.040.830.0940.089720.0001
Overall QoL (1,14)253.2 (21–72)4728.010.850.0740.087730.0001
Emotional well-being (3,4,5, 7,9)558.7 (39.2–87.2)6521.010.790.1490.152720.0001
Energy/fatigue (2,6,8,10)420.0 (11.25–28.75)5319.210.730.0920.071720.0001
Cognitive functioning (12,15,16,17,18,26)650.7 (32.8–68.6)4713.300.810.0730.088730.0002
Medication effects (24,29,30)342.28 (13.86–70.7)3322.820.870.1470.133720.0001
Social functioning (13,19,20,27,28)559.84 (37.42–82.26)5425.330.880.1480.145720.0001
Total score3052.5 (38–67)5319.420.890.0830.091710.0001

The score range = 0–100. n = 73.

Kolmogorov-Smirnov test of normality.

Shapiro-Wilk test of normality.

Regarding criterion validity, Pearson’s correlation coefficients were significant and appropriate for all sub-domains of QOLIE-31 and SF-36. This finding could suggest some specificity of these domains. Table 4 summarizes the appropriate correlation of the two questionnaires’ subscales.
Table 4

Pearson correlations between QOLIE-31 and SF-36 sub-domains (p < 0.05)

SF-36/QOLIE-31SWOQoLEWBE/FCFMESFTQoLIE
BP0.5010.4740.5770.5010.1060.5430.4050.675
GH0.4790.4380.5710.4690.4360.5890.4160.723
MH0.4980.5850.4840.3490.5140.4440.5800.689
PF0.4780.4580.3710.4350.4460.4330.4140.771
RE0.5480.3240.2660.4410.4380.4370.4970.623
RP0.5780.4580.3710.4350.4460.5330.5140.771
SF0.5010.4740.5770.6010.3060.5430.5050.699
VT0.4790.4380.4710.5690.4860.3890.5160.723
TSF-360.3780.4580.5710.5350.4460.4330.4140.871

BP, bodily pain; GH, general health; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality; SW, seizure worry; OQoL, overall quality of life; EWB, emotional well-being; E/F, energy/fatigue; CF, cognitive functioning; ME, medication effects; SF, social functioning; TQoLIE, total scores of overall QoLIE-31, TSF, total scores of SF-36.

Contrast Validity

The exploratory factor analysis demonstrated that the 31-items of QOLIE-31 for aged samples are organized into seven factors (factor 1: seizure worry, factor 2: overall QoL, factor 3: emotional wellbeing, & factor 4: energy/fatigue, factor 5: cognitive, factor 6: social functioning, and factor 7: medication effects) which clarify 94 percent of the scale’s variance. Second-order confirmatory factor analysis pointed out that the factors were well matched up onto a principal factor. According to the Table 5, the rotated factor matrix pattern of Varimax for the QOLIE-31’s subscale questions was considered. Those questions with factor loadings above 0.80 were selected.
Table 5

Varimax rotated factors matrix of the QOLIE-31 (only factor loadings ≥5)

DomainNo. of ItemMeanSDComponents

Factor 1Factor 2Factor 3Factor 4Factor 5Factor 6Factor 7
SW110.400.490.83
SW210.290.460.84
SW220.310.470.87
SW230.310.470.83
SW250.160.470.90
OQoL10.290.370.88
OQoL140.400.460.890.80
EWB30.240.400.81
EWB40.330.490.82
EWB50.360.430.93
EWB70.090.470.80
EWB90.330.480.890.80
E/F20.240.240.95
E/F60.280.470.88
E/F80.170.430.86
E/F100.090.380.82
CF120.090.280.83
CF150.400.460.94
CF160.240.400.90
CF180.330.490.91
CF260.360.430.880.80
SF130.090.470.80
SF190.330.480.80
SF200.240.240.81
SF270.280.470.83
SF280.320.470.87
ME240.270.380.94
ME290.310.460.92
ME300.330.310.91

SW, seizure worry; OQoL, overall quality of life; EWB, emotional well-being; E/F, energy/fatigue; CF, cognitive function; ME, medication effects; SF, social function.

There are covariate between some items i.e. item No. 14 between factors No. 2 and 3, item No. 9 between factors No. 3 and 5, item No. 26 between factors No. 5 and 7 in Persian version of QOLIE-31. It may acclaim that covariate item of the factors like overall QoL, emotional wellbeing, cognitive, and medication effects could be reconstructed as well. Consequently, the 7-factor model was appropriate for the data and the fit index techniques for adjusting the scale. The indexes of the model’s goodness of fit refer to the integrity of the 7-factor model with data. The χ2 to degrees of freedom is less than 2 in efficient models. It is closer to zero and will be closer. The root mean square error of approximation (RMSEA) and standardized root mean residual (SRMR) must be less than 0.05 that indicate to good models. The model pointed out the goodness of fit of the model in the study (AGFI = 0.94, GFI = 0.96, RMSEA = 0.003, IFI = 0.90, NFI = 0.95, CFI = 0.95). As closer measure to 1 in the normed fit index (NFI), the comparative fit index (CFI), goodness-of-fit statistic (GFI), the incremental fit index (IFI), and the adjusted goodness of fit index (AGFI), they refer to the goodness and fit of model. They were more than 0.90 (Table 6).
Table 6

The goodness of fit indexes model

Indexesχ2dfχ2/dfAGFIGFIRMSEAIFINFICFI
Value131.81721.830.940.960.0030.900.950.95

Discussion

The aim of the study is to look for the relevant instrument regarding common symptoms of an nervous-related issue called Epilepsy within aged people in the Iranian social context, even the issue still is challengeable.3,4,9,13,20,21,26 So, the quality of life in epilepsy questionnaire (QOLIE-31, 1993 & 2005) was used and evaluated. The results stated to the well-adjusted psychometric properties, discriminative statistic, reliability, and validity of QOLIE-31 and usefulness of it in the relevant studies too. Regarding the external validity, correlation coefficients were significant and appropriate all sub-domains of QOLIE-31 with SF-36 as well. Therefore, future researchers should not limit themselves to the western scales,7,21 but should also consider specific cultural factors. Persian-language version of QOLIE-31 illustrated appropriate satisfactory psychometric statistics, good reliability, high internal consistency, valuable discriminative characteristics. It has applicable level in the conceptual similarity to the original English-language version. Comparing the results of the study to other similar research indicated to adapting the measures to English, Italian, Bulgarian, Serbian, and French version of QOLIE-31.2,19,30–35 Regarding the findings of the study, the QOLIE-31 is appropriate for validity and reliability in the aged community of the Iranian society and it can be employed to measure quality of life of aged patient with seizure symptoms. Additionally, it is applicable by gerontologists, neuropsychologists, neurophysiologists, geronto-psychiatrics, and neurologists for the future studies as well as to the geriatrics in their diagnostics. Regarding the divergent background, it is first time suggested that in the future studies, the gender-related symptoms of epilepsy and moderating the seizure experience within minorities groups, which are compatible with communities like Iran’s native culture, be conducted and evaluated as well.
  27 in total

1.  Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures.

Authors:  Simon Borghs; Christine de la Loge; Joyce A Cramer
Journal:  Epilepsy Behav       Date:  2012-02-15       Impact factor: 2.937

2.  Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48.

Authors:  J A Cramer; L E Westbrook; O Devinsky; K Perrine; M B Glassman; C Camfield
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

3.  Psychometric evaluation of the Serbian version of the Quality of Life in Epilepsy Inventory-31 (QOLIE-31).

Authors:  Zarko Martinović; Maja Milovanović; Oliver Tosković; Mirjana Jovanović; Nevenka Buder; Perisa Simonović; Rada Dokić
Journal:  Seizure       Date:  2010-08-12       Impact factor: 3.184

4.  Nonconvulsive status epilepticus: the encephalopathic pediatric patient.

Authors:  Hansel M Greiner; Katherine Holland; James L Leach; Paul S Horn; Andrew D Hershey; Douglas F Rose
Journal:  Pediatrics       Date:  2012-02-13       Impact factor: 7.124

5.  Validity and reliability of the Portuguese version of the quality of life in epilepsy inventory (QOLIE-31) for Brazil.

Authors:  Tatiana Indelicato da Silva; Rozana Mesquita Ciconelli; Neide Barreira Alonso; Auro Mauro Azevedo; Ana Carolina Westphal-Guitti; Tatiana Frascarelli Pascalicchio; Carolina Mattos Marques; Luís Otávio Sales Ferreira Caboclo; Joyce A Cramer; Américo Ceiki Sakamoto; Elza Márcia Targas Yacubian
Journal:  Epilepsy Behav       Date:  2007-02-09       Impact factor: 2.937

6.  Examining the relationships of depressive symptoms, stigma, social support and regimen-specific support on quality of life in adult patients with epilepsy.

Authors:  A D Whatley; C K DiIorio; K Yeager
Journal:  Health Educ Res       Date:  2010-02-18

7.  Psychometric properties of the Bulgarian version of the Quality of Life in Epilepsy Inventory (QOLIE-31).

Authors:  Koraliya S Todorova; Valentina S Velikova; Stefan T Tsekov
Journal:  Epilepsy Behav       Date:  2013-06-12       Impact factor: 2.937

8.  A new quality-of-life inventory for epilepsy patients: interim results.

Authors:  K R Perrine
Journal:  Epilepsia       Date:  1993       Impact factor: 5.864

9.  Development of the quality of life in epilepsy inventory.

Authors:  O Devinsky; B G Vickrey; J Cramer; K Perrine; B Hermann; K Meador; R D Hays
Journal:  Epilepsia       Date:  1995-11       Impact factor: 5.864

Review 10.  Ictal epileptic headache: an old story with courses and appeals.

Authors:  Pasquale Parisi; Pasquale Striano; Andrea Negro; Paolo Martelletti; Vincenzo Belcastro
Journal:  J Headache Pain       Date:  2012-09-27       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.